CA2168885A1 - Compositions pour vaccins - Google Patents

Compositions pour vaccins

Info

Publication number
CA2168885A1
CA2168885A1 CA002168885A CA2168885A CA2168885A1 CA 2168885 A1 CA2168885 A1 CA 2168885A1 CA 002168885 A CA002168885 A CA 002168885A CA 2168885 A CA2168885 A CA 2168885A CA 2168885 A1 CA2168885 A1 CA 2168885A1
Authority
CA
Canada
Prior art keywords
vaccine compositions
vaccine composition
hepatitis
mucosal
epitope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002168885A
Other languages
English (en)
Other versions
CA2168885C (fr
Inventor
Steven Neville Chatfield
Mark Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medeva Holdings BV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939316745A external-priority patent/GB9316745D0/en
Application filed by Individual filed Critical Individual
Publication of CA2168885A1 publication Critical patent/CA2168885A1/fr
Application granted granted Critical
Publication of CA2168885C publication Critical patent/CA2168885C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CA002168885A 1993-08-12 1994-07-29 Compositions pour vaccins Expired - Fee Related CA2168885C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939316745A GB9316745D0 (en) 1993-08-12 1993-08-12 Vaccine compositions
GB9316745.0 1993-08-12
PCT/GB1994/001646 WO1995005194A1 (fr) 1993-08-12 1994-07-29 Composition vaccinale

Publications (2)

Publication Number Publication Date
CA2168885A1 true CA2168885A1 (fr) 1995-02-23
CA2168885C CA2168885C (fr) 2007-05-15

Family

ID=38069004

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002168885A Expired - Fee Related CA2168885C (fr) 1993-08-12 1994-07-29 Compositions pour vaccins

Country Status (1)

Country Link
CA (1) CA2168885C (fr)

Also Published As

Publication number Publication date
CA2168885C (fr) 2007-05-15

Similar Documents

Publication Publication Date Title
CA2132547A1 (fr) Vaccins renfermant des vesicules d'agents tensioactifs non ioniques
WO1988008718A1 (fr) Immunisation intranasale contre une infection virale, utilisant un vaccin de sous-unite de glycoproteine virale
EP0992580A3 (fr) Epitopes de lymphocytes T humains immunodominants du virus de l'hépatite C
PT101052A (pt) Proteinas hibridas uteis na preparacao de vacinas
CA2078694A1 (fr) Vaccin contre l'hepatite b
EP0090581A3 (fr) Petits peptides specifiques des antigènes de la fièvre aphteuse
EP0263761A3 (fr) Antigène d'hépatite non-A non-B
GB9316745D0 (en) Vaccine compositions
AU3705793A (en) Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use
AU8010791A (en) Hiv monoclonal antibody
KR920004422A (ko) Hiv의 주요 중화 결정인자
CA2168885A1 (fr) Compositions pour vaccins
US4584195A (en) Broad spectrum vaccine against gonorrhea
US5449765A (en) DNA encoding amino acids 590-710 of glycoprotein gII of pseudorabies virus
AU6461594A (en) Induction of protection against viral infection
US4622223A (en) Broad spectrum vaccine against gonorrhea
CA2160696A1 (fr) Peptides utiles pour la vaccination et l'induction d'anticorps neutralisateurs contre le virus de l'immunodefience humaine
CA2072982A1 (fr) Vaccins contre l'hepatite a
EP0250128A3 (fr) Virus isolé de patients atteints du SIDA
CA2304255A1 (fr) Polypeptides du virus de l'hepatite b
HK167295A (en) Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens
ATE204761T1 (de) Pharmazeutische antigen-/antikörperpräparation
WO2000006197A8 (fr) Vaccin combine d'immunoprophylaxie contre l'hepatite b et d virale, le tetanos et la diphterie
AU2713488A (en) Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed